Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.

NCT07582835 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

355

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Percutaneous Coronary Intervention
Acute Coronary Syndromes
Antiplatelet Therapy
Single Antiplatelet Therapy
Coagulation Factors

Interventions

DRUG: Clopidogrel
DRUG: Ticagrelor
DRUG: Prasugrel

Sponsor

Cardiocentro Ticino